Adjuvant bortezomib and dexamethasone following risk-adapted melphalan and stem cell transplant in patients with light-chain amyloidosis (AL)

被引：0
|
作者：
Landau, H. J.
Hoffman, J.
Hassoun, H.
Elizabeth, H.
Riedel, E.
Nimer, S. D.
Cohen, A.
Comenzo, R. L.
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[2] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA
[3] Tufts Med Ctr, Boston, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8540
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Adjuvant Bortezomib and Dexamethasone Following Risk-Adapted Melphalan and Stem Cell Transplant in Systemic Light-Chain Amyloidosis (AL): A Phase II Study
    Landau, Heather
    Hassoun, Hani
    Cohen, Adam D.
    Lesokhin, Alexander
    Bello, Christina
    Hoover, Elizabeth
    Riedel, Elyn R.
    Ciminiello, Jennifer
    McCullagh, Emily
    Nimer, Stephen D.
    Comenzo, Raymond
    [J]. BLOOD, 2009, 114 (22) : 222 - 223
  • [2] Adjuvant bortezomib and dexamethasone following risk-adapted melphalan and stem cell transplant in systemic AL amyloidosis
    Landau, H.
    Hassoun, H.
    Bello, C.
    Hoover, E.
    Jia, X.
    Riedel, E. R.
    Nimer, S. D.
    Comenzo, R. L.
    [J]. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2010, 17 : 80 - 80
  • [3] Bortezomib and dexamethasone consolidation following risk-adapted melphalan and stem cell transplantation for patients with newly diagnosed light-chain amyloidosis
    Landau, H.
    Hassoun, H.
    Rosenzweig, M. A.
    Maurer, M.
    Liu, J.
    Flombaum, C.
    Bello, C.
    Hoover, E.
    Riedel, E.
    Giralt, S.
    Comenzo, R. L.
    [J]. LEUKEMIA, 2013, 27 (04) : 823 - 828
  • [4] Bortezomib and dexamethasone consolidation following risk-adapted melphalan and stem cell transplantation for patients with newly diagnosed light-chain amyloidosis
    H Landau
    H Hassoun
    M A Rosenzweig
    M Maurer
    J Liu
    C Flombaum
    C Bello
    E Hoover
    E Riedel
    S Giralt
    R L Comenzo
    [J]. Leukemia, 2013, 27 : 823 - 828
  • [5] Consolidation with bortezomib and dexamethasone following risk-adapted melphalan and stem cell transplant in systemic AL amyloidosis
    Landau, H.
    Hassoun, H.
    Bello, C.
    Hoover, E.
    Riedel, E. R.
    Nimer, S. D.
    Comenzo, R. L.
    [J]. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2011, 18 : 135 - 136
  • [6] Bortezomib, Melphalan, and Dexamethasone for Light-Chain Amyloidosis
    Kastritis, Efstathios
    Leleu, Xavier
    Arnulf, Bertrand
    Zamagni, Elena
    Cibeira, Maria Teresa
    Kwok, Fiona
    Mollee, Peter
    Hajek, Roman
    Moreau, Philippe
    Jaccard, Arnaud
    Schoenland, Stefan O.
    Filshie, Robin
    Nicolas-Virelizier, Emmanuelle
    Augustson, Bradley
    Mateos, Maria-Victoria
    Wechalekar, Ashutosh
    Hachulla, Eric
    Milani, Paolo
    Dimopoulos, Meletios A.
    Fermand, Jean-Paul
    Foli, Andrea
    Gavriatopoulou, Maria
    Klersy, Catherine
    Palumbo, Antonio
    Sonneveld, Pieter
    Johnsen, Hans Erik
    Merlini, Giampaolo
    Palladini, Giovanni
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (28) : 3252 - 3260
  • [7] Risk-Adapted Melphalan and Stem Cell Transplantation after Suboptimal Responses to Bortezomib-Based Initial Therapy in Patients with Systemic Light-Chain Amyloidosis (AL)
    Wong, Sandy W.
    Larivee, Denise
    Warner, Melissa
    Sprague, Kellie
    Fogaren, Terry
    Comenzo, Raymond L.
    [J]. BLOOD, 2016, 128 (22)
  • [8] Risk-Adapted Melphalan and Stem Cell Transplant for Systemic Light Chain Amyloidosis: A Single Institution Experience
    Landau, Heather
    Hassoun, Hani
    Bello, Christina
    Chou, Joanne
    Devlin, Sean
    Giralt, Sergio A.
    Comenzo, Raymond
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (02) : S131 - S131
  • [9] MAINTAINED HEMATOLOGIC AND ORGAN RESPONSES FOLLOWING RISK ADAPTED STEM CELL TRANSPLANT (SCT) IN SYSTEMIC LIGHT-CHAIN AMYLOIDOSIS (AL) USING BORTEZOMIB AND DEXAMETHASONE AS CONSOLIDATION THERAPY
    Landau, H. J.
    Hassoun, H.
    Rosenzweig, M. A.
    Bello, C.
    Hoover, E.
    Riedel, E.
    Comenzo, R. L.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (02) : S206 - S206
  • [10] Risk-adapted autologous stem cell transplantation with adjuvant dexamethasone ± thalidomide for systemic light-chain amyloidosis:: results of a phase II trial
    Cohen, Adam D.
    Zhou, Ping
    Chou, Joanne
    Teruya-Feldstein, Julie
    Reich, Lilian
    Hassoun, Hani
    Levine, Beth
    Filippa, Daniel A.
    Riedel, Elyn
    Kewalramani, Tarun
    Stubblefield, Michael D.
    Fleisher, Martin
    Nimer, Stephen
    Comenzo, Raymond L.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2007, 139 (02) : 224 - 233
12345